Ann: Afamelanotide Assists DNA Repair Response Following UVR, page-43

You can hear the desperation from those who were either hoping for lower prices, or those who made the very dumb decision to short one of the best run and highest quality companies (with also one of the largest pipelines) on the ASX

Now with tax loss selling done and dusted, anyone who wants or needs (in the case of shorters) to buy more shares will struggle even more than usual to find liquidity. Won't take much to push this above $20 and higher, especially given the fundamentals already warrant a triple digit share price imo